Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,000

• Price / Volume Information    Yesterday's Closing Price: $79.71 Daily Weekly Monthly 20 Day Moving Average: 750,980 shares Shares Outstanding: 28.91 (millions) Market Capitalization: $2,304.02 (millions) Beta: 2.00 52 Week High: $170.87 52 Week Low: $55.17 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.80% -17.73% 12 Week -50.78% -50.94% Year To Date -38.71% -38.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 04/29/26 Share - Related Items Shares Outstanding: 28.91 Most Recent Split Date: 5.00 (0.03:1) Beta: 2.00 Market Capitalization: $2,304.02 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.06 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.75 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/29/26

• Fundamental Ratios P/E Current FY Estimate: 106.28 Trailing 12 Months: 56.53 PEG Ratio: - Price Ratios Price/Book: 7.48 Price/Cash Flow: 34.37 Price / Sales: 5.39 EPS Growth vs. Year Ago Period: -80.00% vs. Previous Quarter: -71.43% Sales Growth vs. Year Ago Period: 26.50% vs. Previous Quarter: 3.64% ROE 12/31/25 - 14.73 09/30/25 - 20.22 06/30/25 - 16.51 ROA 12/31/25 - 8.67 09/30/25 - 11.89 06/30/25 - 9.35 Current Ratio 12/31/25 - 2.46 09/30/25 - 2.71 06/30/25 - 2.87 Quick Ratio 12/31/25 - - 09/30/25 - 2.59 06/30/25 - 2.70 Operating Margin 12/31/25 - 9.78 09/30/25 - 13.47 06/30/25 - 11.21 Net Margin 12/31/25 - -4.92 09/30/25 - 0.52 06/30/25 - 0.39 Pre-Tax Margin 12/31/25 - -4.94 09/30/25 - 0.62 06/30/25 - 0.42 Book Value 12/31/25 - 10.66 09/30/25 - 10.11 06/30/25 - 9.65 Inventory Turnover 12/31/25 - 10.54 09/30/25 - 10.66 06/30/25 - 10.34 Debt-to-Equity 12/31/25 - 0.16 09/30/25 - 0.18 06/30/25 - 0.19 Debt-to-Capital 12/31/25 - 13.52 09/30/25 - 15.00 06/30/25 - 15.72

Powered by Zacks Investment Research ©